M.Y. Levy
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 4
- Drug Solubulity and Delivery Systems 3
- Advancements in Transdermal Drug Delivery 2
-
- Antibiotics Pharmacokinetics and Efficacy 2
- Fungal Biology and Applications 2
- Co-authors
- Simon Benita (9 shared papers)Claus Führer (1 shared paper)Wolfgang Schütze (1 shared paper)Itzhack Polacheck (5 shared papers)J. Ru̇žička (1 shared paper)Uri Zehavi (4 shared papers)Jiřı́ Janata (1 shared paper)Adam Baszkin (2 shared papers)
In The Last Decade
M.Y. Levy
19 papers receiving 979 citations
Peers
Comparison fields: 5 of 117
- Pharmaceutical Science 475
- Biomaterials 219
- Food Science 184
- Bioengineering 51
- Organic Chemistry 208
Countries citing papers authored by M.Y. Levy
This map shows the geographic impact of M.Y. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.Y. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.Y. Levy more than expected).
Fields of papers citing papers by M.Y. Levy
This network shows the impact of papers produced by M.Y. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.Y. Levy. The network helps show where M.Y. Levy may publish in the future.
Co-authors
The 20 scholars most cited alongside M.Y. Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 272 | |
| 2 | 1993 | 220 | |
| 3 | 1990 | 173 | |
| 4 | 1994 | 85 | |
| 5 | 1989 | 82 | |
| 6 | 1980 | 60 | |
| 7 | 1991 | 40 | |
| 8 | 1986 | 27 | |
| 9 | 1989 | 24 | |
| 10 | 1993 | 15 | |
| 11 | 1995 | 15 | |
| 12 | 1988 | 13 | |
| 13 | 1986 | 13 | |
| 14 | 1989 | 12 | |
| 15 | Short- and long-term stability assessment of a new injectable diazepam submicron emulsion. | 1991 | 8 |
| 16 | 1994 | 7 | |
| 17 | 1993 | 4 | |
| 18 | 1976 | 2 | |
| 19 | 1979 | 1 | |
| 20 | 2025 | 0 |
About M.Y. Levy
M.Y. Levy is a scholar working on Pharmaceutical Science, Pharmacology, Cell Biology, Organic Chemistry and Molecular Biology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (4 papers), Surfactants and Colloidal Systems (4 papers), Advanced Drug Delivery Systems (4 papers), Plant Pathogens and Fungal Diseases (4 papers), Drug Solubulity and Delivery Systems (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Advancements in Transdermal Drug Delivery (2 papers) and Fungal Biology and Applications (2 papers). The work is most often cited by research in Pharmaceutical Science (475 citations), Biomaterials (219 citations), Food Science (184 citations), Bioengineering (51 citations) and Organic Chemistry (208 citations). M.Y. Levy has collaborated with scholars based in Israel, France and Denmark. Frequent co-authors include Simon Benita, Claus Führer, Wolfgang Schütze, Itzhack Polacheck, J. Ru̇žička, Uri Zehavi, Jiřı́ Janata, Adam Baszkin, Yechezkel Barenholz and M. Naim. Their work appears in journals such as International Journal of Pharmaceutics, Pharmaceutical Research, Antimicrobial Agents and Chemotherapy, Medical Mycology and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.